Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro

BACKGROUND: We examined the association of tumor-derived hepatocyte growth factor (HGF) with the clinicopathological features of gliomas and investigated the effect of HGF inhibition on the biological behavior of tumor cells in vitro in order to determine whether HGF is a valuable prognostic predict...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Guo, You-feng, Wang, Xiao-bing, Tian, Xiao-ying, Li, Yang, Li, Bin, Huang, Quan, Zhang, Meng, Li, Zhi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2012
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3447698/
https://ncbi.nlm.nih.gov/pubmed/22741575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-128
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia